A model for in-vitro simultaneous simulation of two different patterns of pharmacokinetic parameters was developed. In the first compartment the initial concentration simulates that seen after intravenous infusion or bolus injection and the antibiotic is diluted at a constant rate. In the second compartment the concentration rises from zero to a maximum of { the maximum of the first concentration. From this second compartment the drug is diluted at a slower rate. In previous studies the bactericidal activity of antibiotics was evaluated under conditions simulating serum pharmacokinetic parameters (Shah, 1980). In this model the initial concentration was as high as the peak serum concentration after an intravenous injection, exposing the bac...
Objectives: To compare in an in vitro kinetic model the pharmacodynamics of moxifloxacin and levoflo...
<p><sup><i>a</i></sup> Concentrations shown represented clinically achievable unbound serum concentr...
The pharmacokinetic properties of anti-infective drugs are a determinant part of treatment success. ...
An in vitro pharmacokinetic/pharmacodynamic perfusion model that simulates a two-compartment open mo...
An in vitro model is described that simulates serum and tissue levels of antibiotic, allowing the ex...
Problems of emerging antibiotic resistance are becoming a serious threat worldwide, and at the same ...
Exposure to antibiotics is an important factor influencing the development of bacterial resistance. ...
We have described an in-vitro pharmacokinetic model that mimics the serum and tissue concentrations ...
A pharmacokinetic-pharmacodynamic (PKPD) model that characterizes the full time course of in vitro t...
Antibiotic resistance is becoming an accelerating issue, both in the treatment of nosocomial infecti...
Nearly all m-vitro kinetic models hitherto employed only consider serum concentration curves of the ...
A new in vitro pharmacokinetic/pharmacodynamic simulator for bacterial biofilms utilizing flow cell ...
Antimicrobial efficacy in vivo is not exclusively defined by the activity of an antibiotic as determ...
The importance of closely observing patients receiving antibiotic therapy, performing therapeutic dr...
Designing antibiotic dosing regimens is often not optimal and the dose-response relationship for mos...
Objectives: To compare in an in vitro kinetic model the pharmacodynamics of moxifloxacin and levoflo...
<p><sup><i>a</i></sup> Concentrations shown represented clinically achievable unbound serum concentr...
The pharmacokinetic properties of anti-infective drugs are a determinant part of treatment success. ...
An in vitro pharmacokinetic/pharmacodynamic perfusion model that simulates a two-compartment open mo...
An in vitro model is described that simulates serum and tissue levels of antibiotic, allowing the ex...
Problems of emerging antibiotic resistance are becoming a serious threat worldwide, and at the same ...
Exposure to antibiotics is an important factor influencing the development of bacterial resistance. ...
We have described an in-vitro pharmacokinetic model that mimics the serum and tissue concentrations ...
A pharmacokinetic-pharmacodynamic (PKPD) model that characterizes the full time course of in vitro t...
Antibiotic resistance is becoming an accelerating issue, both in the treatment of nosocomial infecti...
Nearly all m-vitro kinetic models hitherto employed only consider serum concentration curves of the ...
A new in vitro pharmacokinetic/pharmacodynamic simulator for bacterial biofilms utilizing flow cell ...
Antimicrobial efficacy in vivo is not exclusively defined by the activity of an antibiotic as determ...
The importance of closely observing patients receiving antibiotic therapy, performing therapeutic dr...
Designing antibiotic dosing regimens is often not optimal and the dose-response relationship for mos...
Objectives: To compare in an in vitro kinetic model the pharmacodynamics of moxifloxacin and levoflo...
<p><sup><i>a</i></sup> Concentrations shown represented clinically achievable unbound serum concentr...
The pharmacokinetic properties of anti-infective drugs are a determinant part of treatment success. ...